NUWELLIS, INC. Impairment of Intangible Assets, Finite-lived
NUWELLIS, INC. (NUWE) reported Impairment of Intangible Assets, Finite-lived of $3.80 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2019-02-21
- NUWELLIS, INC. impairment of intangible assets, finite-lived for fiscal 2017 was $3.80M.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|
| 2017-12-31 | $3.80M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |